ClinVar Miner

Submissions for variant NM_000312.4(PROC):c.127G>A (p.Ala43Thr)

gnomAD frequency: 0.00004  dbSNP: rs767626189
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues RCV001801321 SCV002047530 likely pathogenic Thrombophilia due to protein C deficiency, autosomal dominant 2021-12-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003416461 SCV004107110 uncertain significance PROC-related disorder 2023-04-11 criteria provided, single submitter clinical testing The PROC c.127G>A variant is predicted to result in the amino acid substitution p.Ala43Thr. This variant has been reported in the heterozygous state in individuals with type II protein C deficiency and thromboembolic events, however it was also reported in family members who did not have thromboembolic events (Referred to as Ala+t to Thr and G1390 to A, Dodojacek et al. 2000. PubMed ID: 11053623; Table S2, Martos et al. 2019. PubMed ID: 31254973; Table S2, Alhenc-Gelas et al. 2020. PubMed ID: 32717757; Seidel et al. 2020. PubMed ID: 32309994). Of note, one individual noted above also carried the factor V Leiden variant (Seidel et al. 2020. PubMed ID: 32309994). This variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-128178915-G-A). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004690134 SCV005184438 uncertain significance not specified 2024-05-29 criteria provided, single submitter clinical testing Variant summary: PROC c.127G>A (p.Ala43Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 251124 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in PROC causing Thrombophilia Due To Protein C Deficiency, Autosomal Dominant, allowing no conclusion about variant significance. c.127G>A has been reported in the literature in individuals affected with Thrombophilia Due To Protein C Deficiency, Autosomal Dominant (Dodojacek_2000, Martos_2019, Seidel_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 11053623, 31254973, 32309994). ClinVar contains an entry for this variant (Variation ID: 1330289). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.